Administration of IFX in the treatment of refractory colitis has shown high efficacy in several studies; it is recommended by various societies guidelines such as the ASCO and NCCN.33,101 Infliximab is a monoclonal antibody directed against TNF alpha, already in use for IBD and in various rheumatological diseases. The gene discussed is TNF; the disease is colitis.